"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

India embraces GLP-1 medications as a major advance in diabetes and obesity care. Experts warn these drugs require medical supervision and are not simple cosmetic solutions.

Explainer - The popularity of Wegovy and Ozempic has seen a flood of ads pop up. Who can you trust?

Few differences were found for cardiovascular, kidney, and mortality outcomes between liraglutide, semaglutide, and dulaglutide for patients with type 2 diabetes.

GLP-1 receptor agonists have shown promise as treatment for addiction, but there are still several hurdles affecting their ...

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

Biohacker Bryan Johnson has revealed he 'microdosed' weight-loss medications, despite having under 10 percent body fat. The ...

Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...

Costco’s latest perk could help shrink members’ waistlines, while having less of an impact on their wallets. The big-box ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Patients unable to get the jabs through the health service have to fork out hundreds of pounds each month to obtain the ...